Novel oleanolic vinyl boronates: Synthesis and antitumor activity

European Journal of Medicinal Chemistry

Volumn 63, Issue , 2013, Pages 46-56

  Moreira, Vânia M ^a,b   Salvador, Jorge A R ^b,c   Simões, Sérgio ^b,c   Destro, Federica ^d   Gavioli, Riccardo ^d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Apoptosis; Boronates; Oleanolic; Proteasome; Triterpenoids

Indexed keywords

3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)OLEANA 2,12 DIEN 28 AMIDE; 3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)OLEANA 2,12 DIEN 28 OIC ACID; 3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)OLEANA 2,12 DIEN 28 OYL CHLORIDE; BORONIC ACID DERIVATIVE; METHYL 3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)OLEANA 2,12 DIEN 28 OATE; METHYL 3 OXOOLEAN 12 EN 28 OATE; METHYL N [3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)OLEANA 2,12 DIEN 28 OYL]GLYCINATE; METHYL OLEANA 2,12 DIEN 28 OATE 3 TRIFLUOROMETHANESULFONATE; N [3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)OLEANA 2,12 DIEN 28 OYL]GLYCINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BORON COMPOUNDS; CASPASE 3; CASPASE 7; CATALYSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; FLOW CYTOMETRY; HELA CELLS; HUMANS; JURKAT CELLS; K562 CELLS; MESYLATES; MODELS, CHEMICAL; MOLECULAR STRUCTURE; OLEANOLIC ACID; PALLADIUM; PROTEASOME INHIBITORS; VINYL COMPOUNDS;

EID: 84878527939     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2013.01.040     Document Type: Article

References (57)

1. S. Jager, H. Trojan, T. Kopp, M.N. Laszczyk, and A. Scheffler Pentacyclic triterpene distribution in various plants-rich sources for a new group of multi-potent plant extracts Molecules 14 2009 2016 2031
2. J.A.R. Salvador, V.M. Moreira, B.M.F. Goncalves, A.S. Leal, and Y. Jing Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugs Nat. Prod. Rep. 29 2012 1463 1479
3. P. Dzubak, M. Hajduch, D. Vydra, A. Hustova, M. Kvasnica, D. Biedermann, L. Markova, M. Urban, and J. Sarek Pharmacological activities of natural triterpenoids and their therapeutic implications Nat. Prod. Rep. 23 2006 394 411
4. H. Sheng, and H. Sun Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases Nat. Prod. Rep. 28 2011 543 593
5. J. Liu Oleanolic and ursolic acid: research perspectives J. Ethnopharmacol. 100 2005 92 94
6. J.A.R. Salvador, A.S. Leal, and R.C. Santos Semisynthetic pentacyclic triterpenoids in the cancer setting: oleanolic acid and its derivatives J.A.R. Salvador, Pentacyclic Triterpenes as Promising Agents in Cancer 2010 Nova Science Publishers, Inc. 978-1-60876-973-5
7. J. Pollier, and A. Goossens Oleanolic acid Phytochemistry 77 2012 10 15
8. S. Fontanay, M. Grare, J. Mayer, C. Finance, and R.E. Duval Ursolic, oleanolic and betulinic acids: antibacterial spectra and selectivity indexes J. Ethnopharmacol. 120 2008 272 276
9. E.C. Torres-Santos, D. Lopes, R. Rodrigues Oliveira, J.P.P. Carauta, C.A. Bandeira Falcao, M.A.C. Kaplan, and B. Rossi-Bergmann Antileishmanial activity of isolated triterpenoids from Pourouma guianensis Phytomedicine 11 2004 114 120
10. J.-F. Li, Y. Zhao, M.-M. Cai, X.-F. Li, and J.-X. Li Synthesis and evaluation of a novel series of heterocyclic oleanolic acid derivatives with anti-osteoclast formation activity Eur. J. Med. Chem. 44 2009 2796 2806
11. M. Rajasekaran, J.S. Bapna, S. Lakshmanan, A.G. Ramachandran Nair, A.J. Veliath, and M. Panchanadam Antifertility effect in male rats of oleanolic acid, a triterpene from Eugenia jambolana flowers J. Ethnopharmacol. 24 1988 115 121
12. L.I. Somova, F.O. Shode, and M. Mipando Cardiotonic and antidysrhythmic effects of oleanolic and ursolic acids, methyl maslinate and uvaol Phytomedicine 11 2004 121 129
13. L.O. Somova, A. Nadar, P. Rammanan, and F.O. Shode Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension Phytomedicine 10 2003 115 121
14. J.J. Ramírez-Espinosa, M.Y. Rios, S. López-Martínez, F. López-Vallejo, J.L. Medina-Franco, P. Paoli, G. Camici, G. Navarrete-Vázquez, R. Ortiz-Andrade, and S. Estrada-Soto Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches Eur. J. Med. Chem. 46 2011 2243 2251
15. T.J. Raphael, and G. Kuttan Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system Phytomedicine 10 2003 483 489
16. E.M. Giner-Larza, S. Manez, M.C. Recio, R.M. Giner, J.M. Prieto, M. Cerdas-Nicolas, and J.L. Rios Oleanolic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity Eur. J. Pharmacol. 428 2001 137 143
17. J.L. Maia, R.C.P. Lima-Junior, C.M. Melo, J.P. David, J.M. David, A.R. Campos, F.A. Santos, and V.S.N. Rao Oleanolic acid, a pentacyclic triterpene attenuates capsaicin-induced nociception in mice: possible mechanisms Pharmacol. Res. 54 2006 282 286
18. M. Sanchez, C. Theoduloz, G. Schmeda-Hirschmann, I. Razmilic, T. Yanez, and J.A. Rodríguez Gastroprotective and ulcer-healing activity of oleanolic acid derivatives: in vitro-in vivo relationships Life Sci. 79 2006 1349 1356
19. Y. Kashiwada, H.-K. Wang, T. Nagao, S. Kitanaka, I. Yasuda, T. Fujioka, T. Yamagishi, L.M. Cosentino, M. Kozuka, H. Okabe, Y. Ikeshiro, C.-Q. Hu, E. Yeh, and K.-H. Lee Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids 1 J. Nat. Prod. 61 1998 1090 1095
20. P.G. Richardson, T. Hideshima, and K.C. Anderson Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers Cancer Control 10 2003 361 369
21. C.C. Cunningham Talabostat Expert Opin. Investig. Drugs 16 2007 1459 1465
22. S. Baker, C. Ding, T. Akama, Y. Zhang, V. Hernandez, and Y. Xia Therapeutic potential of boron-containing compounds Future Med. Chem. 1 2009 1275 1288
23. A.S. Leal, R. Wang, J.A.R. Salvador, and Y. Jing Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells Bioorg. Med. Chem. 20 2012 5774 5786
24. R.C. Santos, J.A.R. Salvador, R. Cortés, G. Pachón, S. Marín, and M. Cascante New betulinic acid derivatives induce potent and selective antiproliferative activity through cell cycle arrest at the S phase and caspase-dependent apoptosis in human cancer cells Biochimie 93 2011 1065 1075
25. R.C. Santos, J.A.R. Salvador, S. Marín, and M. Cascante Novel semisynthetic derivatives of betulin and betulinic acid with cytotoxic activity Bioorg. Med. Chem. 17 2009 6241 6250
26. J.A.R. Salvador, V.M. Moreira, R.M.A. Pinto, A.S. Leal, and J.A. Paixão Efficient oxidation of oleanolic acid derivatives using magnesium bis(monoperoxyphthalate) hexahydrate (MMPP): a convenient 2-step procedure towards 12-oxo-28-carboxylic acid derivatives Beilstein J. Org. Chem. 8 2012 164 169
27. A.S. Leal, R. Wang, J.A.R. Salvador, and Y. Jing Semisynthetic ursolic acid fluorolactone derivatives inhibit growth with induction of p21waf1 and induce apoptosis with upregulation of NOXA and downregulation of c-FLIP in cancer cells ChemMedChem 2012 1635 1646
28. J.A.R. Salvador, V.M. Moreira, R.M.A. Pinto, A.S. Leal, and C. Le Roux Bismuth(III) triflate catalyzed direct opening of oleanolic hydroxy-γ- lactones to afford 12-oxo-28-carboxylic acids Adv. Synth. Catal. 353 2011 2637 2642
29. R.C. Santos, J.A.R. Salvador, S. Marin, M. Cascante, J.N. Moreira, and T.C.P. Dinis Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid Bioorg. Med. Chem. 18 2010 4385 4396
30. J. Takagi, K. Takahashi, T. Ishiyama, and N. Miyaura Palladium-catalyzed cross-coupling reaction of bis(pinacolato)diboron with 1-alkenyl halides or triflates: convenient synthesis of unsymmetrical 1,3-dienes via the borylation-coupling sequence J. Am. Chem. Soc. 124 2002 8001 8006
31. B.S. Jeong, Y.C. Kim, and E.S. Lee Modification of C2,3,23,28 functional groups on asiatic acid and evaluation of hepatoprotective effects Bull. Korean Chem. Soc. 28 2007 977 982
32. P.J. Stang, M. Hanack, and L.R. Subramanian Perfluoroalkanesulfonic esters: methods of preparation and applications in organic chemistry Synthesis 1982 85 126
33. P.J. Stang, and W. Treptow Single-step improved synthesis of primary and other vinyl trifluoromethanesulfonates Synthesis 1980 283 284
34. T. Honda, G.W. Gribble, N. Suh, H.J. Finlay, B.V. Rounds, L. Bore, F.G. Favaloro, Y.P. Wang, and M.B. Sporn Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages J. Med. Chem. 43 2000 1866 1877
35. Y. Zhang, J. Li, J. Zhao, S. Wang, Y. Pan, K. Tanakad, and S. Kadota Synthesis and activity of oleanolic acid derivatives, a novel class of inhibitors of osteoclast formation Bioorg. Med. Chem. Lett. 15 2005 1629 1632
36. F. Soler, C. Poujade, M. Evers, J.C. Carry, Y. Henin, A. Bousseau, T. Huet, R. Pauwels, E. De Clercq, J.F. Mayaux, J.B. Le Pecq, and D. Dereu Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry J. Med. Chem. 39 1996 1069 1083
37. 5-unsaturated steroids Tetrahedron Lett. 37 1996 687 690
38. X. Jiang, J. Greiner, L. Maravetz, L. Szucs, S. Stephen, M. Visnick, Antioxidant Inflammation Modulators: Novel Derivatives of Oleanolic Acid, WO2009/146216 A2.
39. C.M. Ma, S.Q. Cai, J.R. Cui, R.Q. Wang, P.F. Tu, M. Hattori, and M. Daneshtalab The cytotoxic activity of ursolic acid derivatives Eur. J. Med. Chem. 40 2005 582 589
40. A.B. Charette, and P. Chua A new method for the conversion of secondary and tertiary amides to bridged orthoesters Tetrahedron Lett. 38 1997 8499 8502
41. M.E. Wright, and S.R. Pulley Vinyl triflates: a mechanistic study on their formation from carbonyl compounds and triflic anhydride J. Org. Chem. 54 1989 2886 2889
42. B.G. Sukhov, S.A. Mukha, I.A. Antipova, S.A. Medvedeva, Y.A. Grigorieva, A.I. Illarionov, F.Y. Chuvashev, and B.A. Trofimov Maltol tosylate and triflate possessing nonlinear optical properties Chem. Nat. Compd. 42 2006 1484 1485
43. R. Gavioli, S. Vertuani, and M.G. Masucci Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors Int. J. Cancer 101 2002 532 538
44. Alexei F. Kisselev, W.A. van der Linden, and Herman S. Overkleeft Proteasome inhibitors: an expanding army attacking a unique target Chem. Biol. 19 2012 99 115
45. G. Bettignies, and O. Coux Proteasome inhibitors: dozens of molecules and still counting Biochimie 92 2010 1530 1545
46. C. Franceschini, C. Trapella, F. Sforza, R. Gavioli, M. Marastoni, Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides, J. Enzyme Inhib. Med. Chem. in press.
47. C. Franceschini, C. Trapella, R. Calia, A. Scotti, F. Sforza, R. Gavioli, and M. Marastoni C-terminal trans, trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors J. Enzyme Inhib. Med. Chem. 2012 http://dx.doi.org/10.3109/14756366.2012.709241.
48. M. Bazzaro, R.K. Anchoori, M.K.R. Mudiam, O. Issaenko, S. Kumar, B. Karanam, Z.H. Lin, R.I. Vogel, R. Gavioli, F. Destro, V. Ferretti, R.B.S. Roden, and S.R. Khan α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells J. Med. Chem. 54 2011 449 456
49. H. Yoon, and R.H. Liu Effect of 2α-hydroxyursolic acid on NF-kB activation induced by TNF-α in human breast cancer MCF-7 cells J. Agric. Food Chem. 56 2008 8412 8417
50. H.J. Yang, D. Chen, Q.Z.C. Cui, X. Yuan, and Q.P. Dou Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice Cancer Res. 66 2006 4758 4765
51. H.J. Yang, K.R. Landis-Piwowar, D. Lu, P. Yuan, L.H. Li, G.P.V. Reddy, X. Yuan, and Q.P. Dou Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells J. Cell. Biochem. 103 2008 234 244
52. R.E. Tiedemann, J. Schmidt, J.J. Keats, C.X. Shi, Y.X. Zhu, S.E. Palmer, X. Mao, A.D. Schimmer, and A.K. Stewart Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kB with antimyeloma activity in vitro and in vivo Blood 113 2009 4027 4037
53. G. Sethi, K. SeokAhn, M.K. Pandey, and B.B. Aggarwal Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kB-regulated gene products and TAK1-mediated NF-kB activation Blood 109 2007 2727 2735
54. L. Huang, D.L. Yu, P. Ho, K.D. Qian, K.H. Lee, and C.H. Chen Synthesis and proteasome inhibition of glycyrrhetinic acid derivatives Bioorg. Med. Chem. 16 2008 6696 6701
55. B. Lallemand, F. Chaix, M. Bury, C. Bruyere, J. Ghostin, J.P. Becker, C. Delporte, M. Gelbcke, V. Mathieu, J. Dubois, M. Prevost, I. Jabin, and R. Kiss N-(2-{3-[3,5-Bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity J. Med. Chem. 54 2011 6501 6513
56. K. Qian, S.Y. Kim, H.Y. Hung, L. Huang, C.H. Chen, and K.H. Lee New betulinic acid derivatives as potent proteasome inhibitors Bioorg. Med. Chem. Lett. 21 2011 5944 5947
57. L.H. Meng, R. Mohan, B.H.B. Kwok, M. Elofsson, N. Sin, and C.M. Crews Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity Proc. Natl. Acad. Sci. U.S.A. 96 1999 10403 10408